Slit3 by PTH-Induced Osteoblast Secretion Repels Sensory Innervation in Spine Porous Endplates to Relieve Low Back Pain
Preprint
- 31 August 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
During aging, the spine undergoes degenerative changes, particularly with vertebral endplate bone expansion and sclerosis, that is associated with nonspecific low back pain (LBP). We reported that parathyroid hormone (PTH) treatment could reduce vertebral endplate sclerosis and improve pain behaviors in aging, SM/J and young lumbar spine instability (LSI) mice. Aberrant innervation noted in the vertebral body and endplate during spinal degeneration was reduced with PTH treatment in aging and LSI mice as quantified by PGP9.5+ and CGRP+ nerve fibers, as well as CGRP expression in dorsal root ganglia (DRG). The neuronal repulsion factor Slit3 significantly increased in response to PTH treatment mediated by transcriptional factor FoxA2. PTH type1 receptor (PPR) and Slit3 deletion in osteoblasts prevented PTH-reduction of endplate porosity and improvement in behavior tests, whereas PPR deletion in chondrocytes continued to respond to PTH. Altogether, PTH stimulates Slit3 to repel sensory nerve innervation and provides symptomatic relief of LBP associated with spinal degeneration.Keywords
All Related Versions
This publication has 56 references indexed in Scilit:
- Sympathetic Innervation Regulates Osteocyte‐Mediated Cortical Bone Resorption during LactationAdvanced Science, 2023
- Parathyroid hormone and its related peptides in bone metabolismBiochemical Pharmacology, 2021
- Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysisOsteoporosis International, 2021
- Tissue-specific angiogenic and invasive properties of human neonatal thymus and bone MSCs: Role of SLIT3-ROBO1Stem Cells Translational Medicine, 2020
- Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)Calcified Tissue International, 2016
- Epidemiology of chronic musculoskeletal painBest Practice & Research Clinical Rheumatology, 2011
- Regional variation in vertebral bone morphology and its contribution to vertebral fracture strengthBone, 2007
- Molecular and cellular mechanisms of the anabolic effect of intermittent PTHBone, 2007
- Low back pain (non-specific)Best Practice & Research Clinical Rheumatology, 2007
- Reduced risk of back pain following teriparatide treatment: a meta-analysisOsteoporosis International, 2005